Cargando…

Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma

Cough variant asthma (CVA), a common asthma phenotype characterized by nonproductive cough and bronchial hyperreactivity (BHR), is usually detected by bronchial provocation tests (BPTs) which are time-consuming, expensive, and unsafe. The primary study objective was to provide proof of concept for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Malerba, Mario, Ragnoli, Beatrice, Azzolina, Danila, Montuschi, Paolo, Radaeli, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089476/
https://www.ncbi.nlm.nih.gov/pubmed/33953671
http://dx.doi.org/10.3389/fphar.2021.630334
_version_ 1783687047287930880
author Malerba, Mario
Ragnoli, Beatrice
Azzolina, Danila
Montuschi, Paolo
Radaeli, Alessandro
author_facet Malerba, Mario
Ragnoli, Beatrice
Azzolina, Danila
Montuschi, Paolo
Radaeli, Alessandro
author_sort Malerba, Mario
collection PubMed
description Cough variant asthma (CVA), a common asthma phenotype characterized by nonproductive cough and bronchial hyperreactivity (BHR), is usually detected by bronchial provocation tests (BPTs) which are time-consuming, expensive, and unsafe. The primary study objective was to provide proof of concept for the use of fractional exhaled nitric oxide (F(E)NO), eosinophil count percentage in induced sputum (sEOS%), forced expiratory flow between 25 and 75% of forced vital capacity (FEF(25–75%)) % predicted value, and FEF(25–75%) z-scores as surrogate markers predicting BHR in young adults with suspected CVA; the secondary objective was to compare the diagnostic performance of the various techniques. Three hundred and ten subjects (median age 24 years) were included in a cross-sectional study. Subjects were characterized as BHR positive (POS) (n = 147) or BHR negative (NEG) (n = 163) according to methacholine BPT. Classification accuracies were expressed as areas under the receiver operator characteristic curves (AUC). Compared with BHR NEG, FEF(25–75%) % predicted value and FEF(25–75%) z-scores were lower in the BHR POS group (p < 0.001), whereas F(E)NO (p < 0.001) and sEOS% were higher (p < 0.001). AUC values for detecting BHR were as follows: F(E)NO, 0.98 (SD = 0.02); sEOS%, 0.98 (SD = 0.02); FEF(25–75%) % pred, 0.93 (SD = 0.05); FEF(25–75%) z scores, 0.92 (SD = 0.05). Optimal cutoff values (OCV) for BHR prediction were as follows: F(E)NO, 32.7 ppb (sensitivity = 0.93, specificity = 0.96), sEOS%, 3.80% (sensitivity = 0.94, specificity = 0.94), FEF(25–75%) % predicted value, 80.0% (sensitivity = 0.90, specificity = 0.87), and FEF(25–75%) z-score, −0.87 (sensitivity = 0.89, specificity = 0.87). Non-invasive/semi-invasive airway inflammatory or small airway functional measures might be used as surrogate markers predicting BHR in young adults with suspected CVA.
format Online
Article
Text
id pubmed-8089476
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80894762021-05-04 Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma Malerba, Mario Ragnoli, Beatrice Azzolina, Danila Montuschi, Paolo Radaeli, Alessandro Front Pharmacol Pharmacology Cough variant asthma (CVA), a common asthma phenotype characterized by nonproductive cough and bronchial hyperreactivity (BHR), is usually detected by bronchial provocation tests (BPTs) which are time-consuming, expensive, and unsafe. The primary study objective was to provide proof of concept for the use of fractional exhaled nitric oxide (F(E)NO), eosinophil count percentage in induced sputum (sEOS%), forced expiratory flow between 25 and 75% of forced vital capacity (FEF(25–75%)) % predicted value, and FEF(25–75%) z-scores as surrogate markers predicting BHR in young adults with suspected CVA; the secondary objective was to compare the diagnostic performance of the various techniques. Three hundred and ten subjects (median age 24 years) were included in a cross-sectional study. Subjects were characterized as BHR positive (POS) (n = 147) or BHR negative (NEG) (n = 163) according to methacholine BPT. Classification accuracies were expressed as areas under the receiver operator characteristic curves (AUC). Compared with BHR NEG, FEF(25–75%) % predicted value and FEF(25–75%) z-scores were lower in the BHR POS group (p < 0.001), whereas F(E)NO (p < 0.001) and sEOS% were higher (p < 0.001). AUC values for detecting BHR were as follows: F(E)NO, 0.98 (SD = 0.02); sEOS%, 0.98 (SD = 0.02); FEF(25–75%) % pred, 0.93 (SD = 0.05); FEF(25–75%) z scores, 0.92 (SD = 0.05). Optimal cutoff values (OCV) for BHR prediction were as follows: F(E)NO, 32.7 ppb (sensitivity = 0.93, specificity = 0.96), sEOS%, 3.80% (sensitivity = 0.94, specificity = 0.94), FEF(25–75%) % predicted value, 80.0% (sensitivity = 0.90, specificity = 0.87), and FEF(25–75%) z-score, −0.87 (sensitivity = 0.89, specificity = 0.87). Non-invasive/semi-invasive airway inflammatory or small airway functional measures might be used as surrogate markers predicting BHR in young adults with suspected CVA. Frontiers Media S.A. 2021-04-19 /pmc/articles/PMC8089476/ /pubmed/33953671 http://dx.doi.org/10.3389/fphar.2021.630334 Text en Copyright © 2021 Malerba, Ragnoli, Azzolina, Montuschi and Radaeli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Malerba, Mario
Ragnoli, Beatrice
Azzolina, Danila
Montuschi, Paolo
Radaeli, Alessandro
Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma
title Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma
title_full Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma
title_fullStr Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma
title_full_unstemmed Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma
title_short Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma
title_sort predictive markers of bronchial hyperreactivity in a large cohort of young adults with cough variant asthma
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089476/
https://www.ncbi.nlm.nih.gov/pubmed/33953671
http://dx.doi.org/10.3389/fphar.2021.630334
work_keys_str_mv AT malerbamario predictivemarkersofbronchialhyperreactivityinalargecohortofyoungadultswithcoughvariantasthma
AT ragnolibeatrice predictivemarkersofbronchialhyperreactivityinalargecohortofyoungadultswithcoughvariantasthma
AT azzolinadanila predictivemarkersofbronchialhyperreactivityinalargecohortofyoungadultswithcoughvariantasthma
AT montuschipaolo predictivemarkersofbronchialhyperreactivityinalargecohortofyoungadultswithcoughvariantasthma
AT radaelialessandro predictivemarkersofbronchialhyperreactivityinalargecohortofyoungadultswithcoughvariantasthma